Выбор редакции

Omthera (OMTH) rockets 99% to $13.50 following news that AstraZeneca (AZN) has agreed to acquire the heart-drug company for up to $443M. The upfront payment of $323M is worth $12.70 a share, while a secondary contingent payment of $120M is worth $4.70. AstraZeneca is +2.4%.

Omthera (OMTH) rockets 99% to $13.50 following news that AstraZeneca (AZN) has agreed to acquire the heart-drug company for up to $443M. The upfront payment of $323M is worth $12.70 a share, while a secondary contingent payment of $120M is worth $4.70. AstraZeneca is +2.4%. Post your comment!

НОВОСТИ ПО ТЕМЕ